(Q28274298)

English

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

scientific article

In more languages

Statements

scholarly article

0 references

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C (English)

0 references

0 references

Hepatitis C virus

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

9

object named as

Stefan Zeuzem

0 references

1

object named as

Galia Askarieh

0 references

2

object named as

Asa Alsiö

0 references

Jean-Michel Pawlotsky

7

object named as

Jean-Michel Pawlotsky

0 references

object named as

Martin Lagging

14

0 references

object named as

Carlo Ferrari

5

0 references

11

object named as

Johan Westin

0 references

8

object named as

Solko W Schalm

0 references

3

object named as

Paolo Pugnale

0 references

Gunnar Norkrans

10

object named as

Gunnar Norkrans

0 references

Jonas Söderholm

12

object named as

Jonas Söderholm

0 references

6

object named as

Avidan U Neumann

0 references

author name string

Galia Askarieh

1

0 references

Asa Alsiö

2

0 references

Francesco Negro

4

0 references

Kristoffer Hellstrand

13

0 references

language of work or name

0 references

publication date

May 2010

0 references

0 references

51

0 references

5

0 references

1523-30

0 references

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

IP-10 and type 1 diabetes: a question of time and location.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Triphasic decline of hepatitis C virus RNA during antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

First phase hepatitis c viral kinetics in previous nonresponders patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

First phase viral kinetic parameters and prediction of response to interferon alpha-2b/ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23509

21 January 2018

Identifiers

10.1002/HEP.23509

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28274298&oldid=1766236645"